{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:26:08Z","timestamp":1787153168917,"version":"build-2736575974"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"Supplement_6","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Anticoagulants are one of the leading causes of adverse drug event\u2013related emergency department (ED) visits and emergent hospitalizations, and high rates of inappropriate prescribing practices may be contributing. Nebraska Medicine implemented a direct oral anticoagulant (DOAC) indication-based prescribing panel on March 14, 2022. The goal of the panel is to assist with agent selection, dosing, and monitoring while ensuring indications and quantities are defaulted correctly. The purpose of this study was to assess the impact of an indication-based DOAC panel on appropriate prescribing in the ED.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective chart review included adult patients discharged from the ED with a new DOAC prescription before and after implementation of an indication-based prescribing panel from January 1, 2020, to March 13, 2022, and from July 1, 2022, to September 14, 2023, respectively. Data were analyzed using descriptive statistics, \u03c72 tests, and Student\u2019s t tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 200 patients were included in the final analysis, with 100 in each group. The primary outcome of inappropriate prescriptions occurred in 18% of patients in the pre-panel group and 7% of patients in the post-panel group (P = 0.020). The difference in the proportion of prescriptions requiring pharmacist involvement between the pre- and post-panel groups was statistically significant at 31% vs 17%, respectively (P = 0.020). There was no difference between the groups in the rate of return to the ED within 30 days for any indication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Implementation of an indication-based prescribing panel for DOACs led to a decrease in inappropriate prescribing of DOACs in the ED. Use of the panel decreased the need for pharmacist intervention and resources.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajhp\/zxag028","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T12:39:06Z","timestamp":1769863146000},"page":"S3027-S3032","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the effects of an indication-based panel for prescribing direct oral anticoagulants at discharge from the emergency department of an academic medical center"],"prefix":"10.1093","volume":"83","author":[{"given":"Kristin","family":"Meyer","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical and Nutrition Care, The Nebraska Medical Center , Omaha, NE"},{"name":"University of Nebraska Medical Center, College of Pharmacy , Omaha, NE ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Reha","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Nutrition Care, The Nebraska Medical Center , Omaha, NE ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Gomez","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Nutrition Care, The Nebraska Medical Center , Omaha, NE"},{"name":"University of Nebraska Medical Center, College of Pharmacy , Omaha, NE ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Langenhan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Nutrition Care, The Nebraska Medical Center , Omaha, NE"},{"name":"University of Nebraska Medical Center, College of Pharmacy , Omaha, NE ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"issue":"13","key":"2026081910412260500_zxag028-B1","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1001\/jama.2021.13844","article-title":"US emergency department visits attributed to medication harms, 2017-2019","volume":"326","author":"Budnitz","year":"2021","journal-title":"JAMA"},{"key":"2026081910412260500_zxag028-B2","author":"The Joint Commission"},{"issue":"1","key":"2026081910412260500_zxag028-B3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11606-019-05391-y","article-title":"Emergency visits for oral anticoagulant bleeding","volume":"35","author":"Geller","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"10","key":"2026081910412260500_zxag028-B4","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1093\/europace\/eux316","article-title":"Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA registry","volume":"20","author":"Ortiz","year":"2018","journal-title":"Europace"},{"issue":"6","key":"2026081910412260500_zxag028-B5","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.amjmed.2020.12.022","article-title":"Long-term clinical outcomes of underdosed direct oral anticoagulants in patients with atrial fibrillation and atrial flutter","volume":"134","author":"Ashraf","year":"2021","journal-title":"Am J Med"},{"issue":"12","key":"2026081910412260500_zxag028-B6","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.jacc.2020.07.045","article-title":"Mortality in patients with atrial fibrillation receiving nonrecommended doses of direct oral anticoagulants","volume":"76","author":"Camm","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2026081910412260500_zxag028-B7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.japh.2021.10.027","article-title":"Meta-analysis comparing inappropriately low dose versus standard dose of direct oral anticoagulants in patients with atrial fibrillation","volume":"62","author":"Kido","year":"2022","journal-title":"J Am Pharm Assoc"},{"issue":"4","key":"2026081910412260500_zxag028-B8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/eurheartj\/ehz367","article-title":"Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial","volume":"41","author":"Barco","year":"2020","journal-title":"Eur Heart J"},{"key":"2026081910412260500_zxag028-B9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ajem.2023.03.048","article-title":"Implementation of indication-based antibiotic order sentences improves antibiotic use in emergency departments","volume":"69","author":"Vuong","year":"2023","journal-title":"Am J Emerg Med"},{"issue":"6","key":"2026081910412260500_zxag028-B10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1136\/bmjqs-2022-015452","article-title":"Indication documentation and indication-based prescribing within electronic prescribing systems: a systematic review and narrative synthesis","volume":"32","author":"Feather","year":"2023","journal-title":"BMJ Qual Saf"},{"issue":"17","key":"2026081910412260500_zxag028-B11","doi-asserted-by":"publisher","first-page":"e457","DOI":"10.1093\/ajhp\/zxae149","article-title":"Implementation of a pharmacist-developed, indication-based order panel for outpatient prescribing of direct-acting oral anticoagulants","volume":"81","author":"Trueman","year":"2024","journal-title":"Am J Health-Syst Pharm"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxag028\/66725665\/zxag028.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/83\/Supplement_6\/S3027\/66725665\/zxag028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/83\/Supplement_6\/S3027\/66725665\/zxag028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:41:30Z","timestamp":1787150490000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/83\/Supplement_6\/S3027\/8456292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":11,"journal-issue":{"issue":"Supplement_6","published-online":{"date-parts":[[2026,2,3]]},"published-print":{"date-parts":[[2026,8,19]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxag028","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9,1]]},"published":{"date-parts":[[2026,2,3]]}}}